Study Stopped
Investigator's decision
Response of the Autonomic Nervous System to Auricular Stimulation of the Vagus Nerve (x)
AURIX
1 other identifier
interventional
10
1 country
1
Brief Summary
While invasive vagal stimulation has proven its therapeutic effectiveness over the past 20 years, particularly in the treatment of epilepsy or depression, its implementation is hampered by the high cost, high technicality and sometimes significant side effects. Non-invasive vagal stimulation, most often electric, is a less expensive therapeutic alternative and easier to implement, although the level of evidence is lower than that of invasive stimulation. Some so-called traditional therapies, such as acupuncture, also stimulate certain parts of the ear by mechanical means, most often by puncturing the ear or the concha. In these traditional therapies, more than one hundred stimulation points have been described, each precisely positioned according to an empirical topography. However, electrical non-invasive stimulation recognizes only three areas of interest on the ear, which are the areas of sensitive innervation, namely the afferences of the vagus nerve in the concha, which is the only one used in practice, the large occipital nerve on the lobe and part of the helix, and the auriculotemporal nerve on the rest of the auricular flag. In this study, we would like to explore the justification for the topographic precision, adopted by traditional therapies, for non-invasive vagal stimulation on the concha.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 17, 2019
CompletedFirst Submitted
Initial submission to the registry
October 16, 2019
CompletedFirst Posted
Study publicly available on registry
October 18, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 21, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
November 21, 2019
CompletedSeptember 25, 2025
January 1, 2022
10 months
October 16, 2019
September 24, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Skin temperature changes
measured by thermocouples placed on the following fingers: thumb, middle finger and ear of the right hand. The values and times of the minimum and maximum temperatures (latency and amplitude of (CIVD) Cold-Induced VasoDilatation waves) are measured
20 minutes
Secondary Outcomes (1)
Pain reported by the participant
20 minutes
Other Outcomes (1)
Sinus variability
20 minutes
Study Arms (2)
A stimulation of G13 then G15
EXPERIMENTALThe first session is similar between the two arms: Cold water hand immersion only At the Second session: Cold water hand immersion + G13 auricular stimulation At the Third session: Cold water hand immersion + G15 auricular stimulation
B: stimulation of G15 then G13
EXPERIMENTALThe first session is similar between the two arms: Cold water hand immersion only At the Second session: Cold water hand immersion + G15 auricular stimulation At the Third session: Cold water hand immersion + G13 auricular stimulation
Interventions
Study participant randomized into arm A will undergo a stimulation of point G13 at session N°2, then stimulation of point G15 at session N°3.
Study participant randomized into arm B will undergo a stimulation of point G15 at session N°2, then stimulation of point G13 at session N°3.
Eligibility Criteria
You may qualify if:
- Healthy volunteers, male and female, aged 18 to 60 years
- BMI (Body mass index) \<=30
- Not participating in another clinical study with an investigational product
You may not qualify if:
- Drug treatment for cardiological, neurological or anticoagulant purposes
- History of diabetes, known neuropathy, high blood pressure, heart rhythm disorders, syncope or palpitation
- Known cryoglobulinemia
- Subject with Raynaud's syndrome
- Intra-auricular device of the piercing type,
- Psychoactive substance use, excessive alcohol consumption (\>2 units per day chronically or \>6 units per day recreationally) and tobacco (\>5 cigarettes per day)
- Subject unable to read French
- Subject covered by Articles L1121-5 to 1121-8 of the Public Health Code, namely:
- Pregnant, postpartum and breastfeeding women
- Persons deprived of their liberty by a judicial or administrative decision
- Persons undergoing psychiatric care under Articles L3112-1 and L3113-1 who are not covered by the provisions of Article L1121-8
- Minors
- Persons of full age who are subject to a legal protection measure or who are unable to express their consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hôpital Européen Marseillelead
- Aix Marseille Universitécollaborator
Study Sites (1)
Hôpital Européen Marseille
Marseille, PACA, 13003, France
Related Publications (1)
Sagui E, Claverie D, Bidaut W, Grelot L. Heart rate variability and cold-induced vascular dilation after stimulation of two different areas of the ear: a prospective, single-blinded, randomized crossover study. BMC Complement Med Ther. 2024 Feb 13;24(1):83. doi: 10.1186/s12906-024-04392-7.
PMID: 38350937DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Emmanuel SAGUI, MD
Hôpital Européen Marseille
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 16, 2019
First Posted
October 18, 2019
Study Start
January 17, 2019
Primary Completion
November 21, 2019
Study Completion
November 21, 2019
Last Updated
September 25, 2025
Record last verified: 2022-01